Hologic, a medtech company focused on women’s health, has announced a definitive agreement to acquire Gynesonics, a privately held medical device company. The acquisition is valued at approximately $350 million, subject to working capital and other customary closing adjustments.
Gynesonics is known for developing the Sonata System, designed for diagnostic intrauterine imaging and transcervical treatment of certain symptomatic uterine fibroids, including those associated with heavy menstrual bleeding. The Sonata System combines real-time intrauterine ultrasound guidance with targeted radiofrequency ablation in an incisionless procedure.
Brandon Schnittker, Division President of Surgical Solutions at Hologic, commented on the acquisition: “Gynesonics’ Sonata System complements our offering and will give GYN surgeons across the globe an expanded range of options to treat women suffering from heavy periods and fibroids. This acquisition furthers our commitment to providing women with minimally invasive treatment options. We are enthusiastic about the future as we work to expand access to and drive innovation for treatments that enhance women’s quality of life.”
The acquisition is subject to customary closing conditions, including receipt of required regulatory approvals.
